Dr. Reddys Laboratories Ltd.

Further to intimations dated August 20, 2019 and February 16, 2020 with regard to the audit of Formulations Manufacturing Plant (Vizag SEZ Plant I - PTO 7) at Duvvada, Visakhapatnam, Dr. Reddys Laboratories has informed that the Company received the Establishment Inspection Report (EIR) from US FDA, for the above-referred facility, indicating closure of the audit. As intimated earlier the facility has been classified as V AI (Voluntary Action Indicated).

The above information is a part of company’s filings submitted to BSE.